Pre-Alpha Prototype for Pathogen Detection Successfully De-Risked and Unveiling Scheduled
Jul 06, 2017 12:30 pm UTC| Business
VANCOUVER, British Columbia, July 06, 2017 -- LexaGene Holdings Inc. (OTCQB:LXXGF) (TSX-V:LXG) (the “Company”), a biotechnology company that develops instrumentation for pathogen detection, today announced that the...
Jul 06, 2017 12:30 pm UTC| Business
Study is being conducted in the US, Europe, and IsraelTop line data expected end of 2017 or early 2018 HAYWARD, Calif., July 06, 2017 -- Anthera (Nasdaq:ANTH) today announced that it has commenced screening in Europe...
PositiveID’s E-N-G Mobile Systems Launches New Marketing Video
Jul 06, 2017 12:30 pm UTC| Business
DELRAY BEACH, Fla., July 06, 2017 -- PositiveID Corporation (OTCQB:PSID), a life sciences company focused on detection and diagnostics, announced today its E-N-G Mobile Systems (ENG) subsidiary has launched a new video...
Jul 06, 2017 12:30 pm UTC| Business
MENLO PARK, Calif., July 06, 2017 -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal...
Endeavour Announces the Retirement of its COO, Attie Roux, Who Will Be Succeeded by Jeremy Langford
Jul 06, 2017 12:17 pm UTC| Business
ENDEAVOUR ANNOUNCES THE RETIREMENT OF ITS COO, ATTIE ROUX, WHO WILL BE SUCCEEDED BY JEREMY LANGFORD View News Release in PDF Format Abidjan, July 6, 2017 - Endeavour Mining (TSX:EDV OTCQX:...
Avaap Successfully Implements Infor CloudSuite™ Financials at Palos Health
Jul 06, 2017 12:01 pm UTC| Business
EDISON, N.J., July 06, 2017 -- Avaap, the largest IT services provider strategically focused on Infor and Epic software, today announced the successful go-live implementation of Infor CloudSuite Financials tightly...
Financial Milestone Achieved in Catalyst’s Subcutaneous Factor IX Program
Jul 06, 2017 12:01 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., July 06, 2017 -- Catalyst Biosciences, Inc. (Nasdaq:CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology indications, today announced...